Aldeyra Therapeutics Inc (ALDX)
4.40
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 12:41
Aldeyra Therapeutics Total Liabilities (Quarterly): 27.73M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 27.73M |
| March 31, 2024 | 27.88M |
| December 31, 2023 | 28.53M |
| September 30, 2023 | 24.27M |
| June 30, 2023 | 25.73M |
| March 31, 2023 | 30.98M |
| December 31, 2022 | 30.28M |
| September 30, 2022 | 27.50M |
| June 30, 2022 | 26.99M |
| March 31, 2022 | 32.00M |
| December 31, 2021 | 27.40M |
| September 30, 2021 | 27.55M |
| June 30, 2021 | 22.75M |
| March 31, 2021 | 21.23M |
| December 31, 2020 | 23.84M |
| September 30, 2020 | 19.15M |
| June 30, 2020 | 18.84M |
| March 31, 2020 | 19.56M |
| December 31, 2019 | 27.44M |
| September 30, 2019 | 26.56M |
| June 30, 2019 | 6.506M |
| March 31, 2019 | 9.648M |
| December 31, 2018 | 8.473M |
| Date | Value |
|---|---|
| September 30, 2018 | 8.536M |
| June 30, 2018 | 6.305M |
| March 31, 2018 | 4.775M |
| December 31, 2017 | 4.574M |
| September 30, 2017 | 3.324M |
| June 30, 2017 | 3.128M |
| March 31, 2017 | 3.537M |
| December 31, 2016 | 3.538M |
| September 30, 2016 | 3.520M |
| June 30, 2016 | 3.366M |
| March 31, 2016 | 2.910M |
| December 31, 2015 | 3.326M |
| September 30, 2015 | 2.655M |
| June 30, 2015 | 2.353M |
| March 31, 2015 | 2.105M |
| December 31, 2014 | 2.503M |
| September 30, 2014 | 2.087M |
| June 30, 2014 | 1.990M |
| March 31, 2014 | 4.027M |
| December 31, 2013 | 5.647M |
| September 30, 2013 | 14.58M |
| December 31, 2012 | 27.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
18.84M
Minimum
Jun 2020
32.00M
Maximum
Mar 2022
25.77M
Average
27.40M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 137.35B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.04M |
| Shareholders Equity (Quarterly) | 98.31M |